Cite
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation.
MLA
Pertsinidou, Eleftheria, et al. “In Early Rheumatoid Arthritis, Anticitrullinated Peptide Antibodies Associate with Low Number of Affected Joints and Rheumatoid Factor Associates with Systemic Inflammation.” Annals of the Rheumatic Diseases, vol. 83, no. 3, Mar. 2024, pp. 277–87. EBSCOhost, https://doi.org/10.1136/ard-2023-224728.
APA
Pertsinidou, E., Saevarsdottir, S., Manivel, V. A., Klareskog, L., Alfredsson, L., Mathsson-Alm, L., Hansson, M., Cornillet, M., Serre, G., Holmdahl, R., Skriner, K., Jakobsson, P.-J., Westerlind, H., Askling, J., & Rönnelid, J. (2024). In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation. Annals of the Rheumatic Diseases, 83(3), 277–287. https://doi.org/10.1136/ard-2023-224728
Chicago
Pertsinidou, Eleftheria, Saedis Saevarsdottir, Vivek Anand Manivel, Lars Klareskog, Lars Alfredsson, Linda Mathsson-Alm, Monika Hansson, et al. 2024. “In Early Rheumatoid Arthritis, Anticitrullinated Peptide Antibodies Associate with Low Number of Affected Joints and Rheumatoid Factor Associates with Systemic Inflammation.” Annals of the Rheumatic Diseases 83 (3): 277–87. doi:10.1136/ard-2023-224728.